Hagop M. Kantarjian
University of Texas MD Anderson Cancer Center
4152 Papers
32.7K Citations
Hagop M. Kantarjian is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Myeloid leukemia. The author has an hindex of 204, co-authored 3708 publications. Previous affiliations of Hagop M. Kantarjian include Rice University & University of Chicago.
Chat about Author
Papers
Fusarium. A newly recognized fungal pathogen in immunosuppressed patients.
Elias Anaissie,Elias Anaissie,Hagop M. Kantarjian,Paula G. Jones,Barthel Barlogie,Mario A. Luna,Gabriel‐Berestein ‐B Lopez,Gerald P. Bodey +7 more
TL;DR: This report and review of the recent literature suggest that Fusarium is emerging as a newly recognized fungal pathogen in immunosuppressed patients.
81
•Journal Article
DNA Methylation Patterns at Relapse in Adult Acute Lymphocytic Leukemia
Guillermo Garcia-Manero,Carlos E. Bueso-Ramos,Jerry Daniel,Jason Williamson,Hagop M. Kantarjian,Jean Pierre J. Issa +5 more
TL;DR: DNA methylation patterns are stable in a majority of patients with relapsed ALL, but a subset of patients acquire new methylation changes, in particular affecting cell cycle regulatory genes.
81
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia
Paolo Strati,Michael J. Keating,William G. Wierda,Xavier Badoux,Steliana Calin,James M. Reuben,Susan O'Brien,Steven M. Kornblau,Hagop M. Kantarjian,Hui Gao,Alessandra Ferrajoli +10 more
TL;DR: Patients with chronic lymphocytic leukemia treated with an initial therapy of lenalidomide had lower baseline plasma levels of β-2-microglobulin, were more likely to have trisomy 12, and less likely than other patients to have deletion 17p.
81
Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.
Alejandro Majlis,Terry L. Smith,Moshe Talpaz,Susan O'Brien,Mary Beth Rios,Hagop M. Kantarjian +5 more
TL;DR: The prognostic significance of clonal evolution in CML is not uniform and is related to the specific abnormality, time to its development, its predominance in metaphases, and the presence of other accelerated features, and it may be modified by specific therapies.
80
•Journal Article
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia
Alessandra Ferrajoli,Taghi Manshouri,Zeev Estrov,Michael J. Keating,Susan O'Brien,Susan Lerner,Miloslav Beran,Hagop M. Kantarjian,Emil J. Freireich,Maher Albitar +9 more
TL;DR: The data indicate that cellular VEGFR-2 levels may serve as a prognostic factor in CLL, and the effect of the interaction between VEGF and VEGfr-2 on CLL cell proliferation is investigated.
80